InnoCon Medical has achieved the next milestone in its development. Our innovative device UCon has received the approval from the Danish Medicines Agency to initiate clinical investigations. It will be performed together with our long-term clinical partners from Aarhus University Hospital, Odense University Hospital, and Herlev Hospital. In this study the focus will be on our patented Patch Electrode and will include people with overactive bladder and fecal incontinence.